Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

4 Résultats
Structure : Identifiant HAL de la structure : 490655

Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial

Francoise Kraeber-Bodere , Amandine Pallardy , Hervé Maisonneuve , Loïc Campion , Anne Moreau , et al.
The Lancet Haematology, 2017, 4 (1), pp.e35-e45. ⟨10.1016/S2352-3026(16)30168-5⟩
Article dans une revue hal-02425339v1

Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study

Federico Garnier , Alain Duhamel , Ibrahim Yakoub-Agha , Alexis Caulier , Elodie Drumez , et al.
Article dans une revue hal-03605967v1

A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study

Karim Labreche , Mailys Daniau , Amit Sud , Philip J Law , Louis Royer-Perron , et al.
Neuro-Oncology, 2019, 21 (8), pp.1039-1048. ⟨10.1093/neuonc/noz088⟩
Article dans une revue hal-02328989v1
Image document

Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma

J. Biau , E. Thivat , E. Chautard , D. Stefan , Mathieu Boone , et al.
Radiotherapy & Oncology, 2021, 154 (227-234), ⟨10.1016/j.radonc.2020.09.036⟩
Article dans une revue hal-02954534v1